Literature DB >> 8684234

Long-term tacrine treatment in patients with Alzheimer's disease.

P R Solomon, M J Knapp, S I Gracon, M Groccia, W W Pendlebury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8684234     DOI： 10.1016/s0140-6736(05)65594-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.

Authors:  M Rösler; R Anand; A Cicin-Sain; S Gauthier; Y Agid; P Dal-Bianco; H B Stähelin; R Hartman; M Gharabawi
Journal:  BMJ       Date:  1999-03-06

Review 2.  Rivastigmine. A review of its use in Alzheimer's disease.

Authors:  C M Spencer; S Noble
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.